戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1  infection and continuing during infection and recovery one of the following: 1) a normal low fat (13% kcal) diet, 2) a l
2 , and congenital defects in pregnant women treated with any of the following: 1) a vitamin K antagonist (VKA) throughout
3 alization within the previous 36 h, active dyspnea, and any of the following: 1) estimated glomerular filtration rate <60
4 irus-positive patients (n = 943) were defined as having any of the following: a kidney biopsy with PV associated nephropa
5 in the break phase of an LF-ISO cycle, reduce the intensity of the following active phase by stabilizing the atmosphere.
6 pants were healthy controls and individuals with at least 1 of the following anxiety disorders: generalized anxiety disor
7 etail-based primary eye clinics were enrolled based on >/=1 of the following at-risk criteria for glaucoma: AD aged >/=40
8 s if they had no history of atrial fibrillation but had any of the following: CHA2DS2-VASc score of >/=2, sleep apnea, or
9 016, consecutive outpatients were eligible if they had >/=1 of the following: chest/abdominal/back pain, syncope, perfusi
10                          MET-driven PRCC was defined as any of the following: chromosome 7 copy gain, focal MET or HGF ge
11 ructed; one single and one double storey building with each of the following claddings: bamboo, shade net, and timber.
12                     All trials compared gatifloxacin with 1 of the following comparator drugs: cefixime, chloramphenicol,
13                                    Patients had to meet all of the following criteria: hospitalized for cIAI requiring in
14 bocytopenic events (CRTE) during weeks 5-12, defined as one of the following events, either alone or in combination: grad
15 dermal separation was significantly reduced by blocking any of the following: Fcgamma receptor binding (P = 0.048), eosin
16 viruses, pigs were genetically modified (GM) to possess one of the following genotypes: complete knockout (KO) of CD163,
17 rom 922 households were randomised between 2012-2013 to one of the following groups: usual care (n = 338); postal pedomet
18 tissue was prepared and processed according to requirements of the following: in situ hybridization, immunohistochemistry
19  initial insights into an ordered fusion pathway consisting of the following intermediates and events: 1) Rab- and HOPS-t
20  the primary composite measure of HI-EOL care comprised any of the following: intravenous chemotherapy < 14 days from dea
21 far all XPCI implementations have suffered from one or more of the following limitations: low x-ray energies, small field
22 ctor aryl hydrocarbon receptor, could change the expression of the following liver transporters involved in drug clearanc
23                                                Calculations of the following molar ratios: Zn:Cu, Fe:Zn, and Fe:Mn, pairs
24 from Europe, and one from China) that assessed combinations of the following MPOWER policies: smoke-free legislation (n=3
25 ool hazard ratios (HRs) with 95% confidence intervals (CIs) of the following outcomes: acute cardiac event; stroke; venou
26  segmentation software was applied to determine thicknesses of the following parameters: total retinal thickness, inner r
27 ation, CCA was transfected intraluminally (15 min) with one of the following: polyethylenimine (PEI)+TSP-2 siRNA, saline,
28 , and psychotic symptoms scoring at least 4 on at least one of the following Positive and Negative Syndrome Scale (PANSS)
29 epatocellular Carcinoma; HALT-HCC) assessed the association of the following previously reported variables of interest wi
30  to specific agent, Group I exhibited higher concentrations of the following proteins compared to Group II: fibrinogen (m
31 management of patients with ELVO were instructed on the use of the following protocol for patients presenting with a Los
32 tcome was biochemical-clinical failure (BCF) defined by any of the following: PSA failure (nadir + 2), hormonal intervent
33 domly assigned patients in a 2:2:2:1:1 ratio to receive one of the following regimens: tofacitinib at a 5-mg dose taken o
34 ions with PaCO2 >/= 45 mm Hg, pH </= 7.35, and at least one of the following: respiratory rate >/= 25/min, PaO2 </= 50 mm
35 sis participants who identified in 2011 as belonging to one of the following seven largest ethnic groups: white British,
36  from November 11, 2012, to September 23, 2013, who met one of the following shock criteria: 1) systolic blood pressure l
37                                     This framework consists of the following steps: (1) in vitro HLM/S9 assay, (2) in viv
38            The automatable compMS(2)Miner workflow consists of the following steps: (i) matching unknown MS(1) features t
39                                The hiCLIP protocol consists of the following steps: in vivo cross-linking of RBPs to thei
40 ing in older survivors of breast cancer, with consideration of the following strategy for women 70 years or older: 1-time
41                         Participants were randomized to one of the following study arms: view a one minute family video m
42 than 50% to 90% predicted at screening, and had one or more of the following symptoms within the 7 days before randomisat
43 ned as autonomic failure at autonomic function testing or 2 of the following symptoms: urinary symptoms, constipation, up
44       The novelty of this study consists in the combination of the following three drying free convection (at 50, 60, and
45                   The resting-state functional connectivity of the following three regions with the SCC was differentiall
46 le for both RFA and SBRT to evaluate the cost-effectiveness of the following treatment strategies: (a) SBRT as initial tr
47                             Newly emerged bees were fed one of the following treatments for 15 and 30 days: three concent
48 nd functional magnetic resonance imaging during performance of the following validated decision-making tasks: delay disco
49 eatment for mCNV was categorized as the administration of 1 of the following within the first 365 days after the diagnosi
50            Additionally, eligible patients had at least one of the following within the screening period of 4 weeks: plat

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。